Wordt geladen...
MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia
Loss of miR-15/16 is the most common genetic lesion in chronic lymphocytic leukemia (CLL), promoting overexpression of BCL2, which factors in leukemia pathogenesis. Indeed, an inhibitor of Bcl2, venetoclcax, is highly active in the treatment of patients with CLL. However, single-agent venetoclcax fa...
Bewaard in:
| Gepubliceerd in: | Proc Natl Acad Sci U S A |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
National Academy of Sciences
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635897/ https://ncbi.nlm.nih.gov/pubmed/28923920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1708264114 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|